Clorox stock (US1890541097): BNP Paribas cuts price target to $97

Clorox faced renewed analyst pressure on May 12, 2026, when BNP Paribas adjusted its price target downward to $97 per share from $128, maintaining a neutral rating on the stock, according to MarketScreener as of May 12, 2026. The stock traded at $88.90 USD on May 11, 2026, down 3.54% for the day, according to GuruFocus as of May 11, 2026.

As of: May 12, 2026

By the editorial team – specialized in equity coverage.

Clorox: core business model

The Clorox Company is a leading manufacturer and marketer of consumer and professional products sold through mass retail, e-commerce, and institutional channels. The company's portfolio spans bleach-based cleaners, disinfectants, water filtration systems, food products, and specialty chemicals. Clorox operates in a mature but resilient market where brand recognition and product innovation drive competitive positioning. The company serves both household consumers and professional cleaning segments, with significant exposure to North American markets and growing international operations.

Main revenue and product drivers for Clorox

Clorox's revenue streams are anchored in its core cleaning and disinfection portfolio, which includes iconic brands such as Clorox bleach, Lysol disinfectants, and Clorox wipes. The company also generates substantial revenue from water filtration products under the Brita brand and food-related offerings. Margin pressures from raw material costs, supply chain volatility, and competitive pricing have been persistent headwinds. The company's ability to pass through cost increases to consumers while maintaining market share remains a key operational challenge in an inflationary environment.

Analyst perspective and valuation pressure

The BNP Paribas downgrade reflects broader concerns about Clorox's valuation and near-term earnings trajectory. The $31 reduction in the price target—a 24% cut—signals analyst skepticism about the company's ability to sustain premium valuations amid consumer spending pressures and margin compression. The neutral rating suggests limited upside catalysts in the near term. Consensus analyst opinion remains mixed, with 19 analysts covering the stock and a mean consensus rating of hold, according to MarketScreener data. The average price target across all analysts stands at $105.59, implying 18.77% upside from the May 11 close, though this reflects divergent views on the company's trajectory.

Conclusion

Clorox faces a challenging near-term environment characterized by analyst skepticism, valuation pressure, and stock price volatility. The BNP Paribas downgrade underscores concerns about the company's ability to navigate margin pressures and consumer spending dynamics. While the company maintains strong brand equity and market position in household products, the divergence between analyst price targets and current trading levels reflects uncertainty about near-term catalysts. US investors should monitor quarterly earnings reports, cost inflation trends, and management guidance for signs of stabilization or further deterioration in the company's operational performance.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.